Autosomal monosomies among 24,262 consecutive cytogenetic studies

Prevalence, chromosomal distribution and clinicopathologic correlates of sole abnormalities

Sania Raza, Fareeda Tahernazerhussain, Mrinal M Patnaik, Ryan Knudson, Daniel Van Dyke, Ayalew Tefferi

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

Monosomal karyotype (MK) has recently been associated with poor prognosis in acute myeloid leukemia (AML), myelodysplastic syndromes (MDS), and primary myelofibrosis (PMF). The objectives of the current study were to describe the prevalence and spectrum of autosomal monosomies in an unselected cohort of patients with known or suspected hematologic malignancies. Bone marrow cytogenetic studies (24,262) were performed at our institution between 1989 and 2009. An abnormal karyotype was demonstrated in 6,565 cases (∼27%); of these, 1,365 (∼21%) included autosomal monosomies that occurred as sole (n = 133; ∼10%), part of two (n = 82; ∼6%) or more (n = 1,150; ∼84%) anomalies. All 22 autosomes were involved, but monosomy 7 was by far the most frequent, constituting ∼80% of all isolated monosomies and the highest fraction of those with two or more abnormalities. Other recurrent sole monosomies included chromosomes 20 (∼11%) and 21 (∼4%). Monosomy 13 (∼10%), 20 (∼8%), 18 (∼7%), 17 (∼6%), 21 (∼5%), 5 (∼5%), and 12 (∼4%) were also recurrent in the setting of ≥2 abnormalities. Bone marrow histology and clinical information were reviewed in all cases with isolated monosomy; associated clinical phenotypes were MDS (n = 60; 52 were -7), AML (n = 32; 31 were -7), myeloproliferative neoplasms (n = 16; 10 were -7), chronic myelomonocytic leukemia (CMML; n = 10; 9 were -7) and other nonmyeloid malignancies (n = 15; 4 were -7). Sole monosomy 20 (n = 14; six MDS, five MPN, and three nonmyeloid) was not seen in AML or CMML. Sole monosomy 21 was more frequent in nonmyeloid as opposed to myeloid cases.

Original languageEnglish (US)
Pages (from-to)353-356
Number of pages4
JournalAmerican Journal of Hematology
Volume86
Issue number4
DOIs
StatePublished - Apr 2011

Fingerprint

Monosomy
Cytogenetics
Cross-Sectional Studies
Myelodysplastic Syndromes
Acute Myeloid Leukemia
Bone Marrow
Leukemia, Myelomonocytic, Chronic
Chromosomes, Human, Pair 20
Abnormal Karyotype
Chromosomes, Human, Pair 21
Chromosomes, Human, Pair 11
Primary Myelofibrosis
Hematologic Neoplasms
Karyotype
Neoplasms
Histology
Phenotype

ASJC Scopus subject areas

  • Hematology

Cite this

Autosomal monosomies among 24,262 consecutive cytogenetic studies : Prevalence, chromosomal distribution and clinicopathologic correlates of sole abnormalities. / Raza, Sania; Tahernazerhussain, Fareeda; Patnaik, Mrinal M; Knudson, Ryan; Van Dyke, Daniel; Tefferi, Ayalew.

In: American Journal of Hematology, Vol. 86, No. 4, 04.2011, p. 353-356.

Research output: Contribution to journalArticle

@article{4942afbc1f374f85a261198ad1eba1f2,
title = "Autosomal monosomies among 24,262 consecutive cytogenetic studies: Prevalence, chromosomal distribution and clinicopathologic correlates of sole abnormalities",
abstract = "Monosomal karyotype (MK) has recently been associated with poor prognosis in acute myeloid leukemia (AML), myelodysplastic syndromes (MDS), and primary myelofibrosis (PMF). The objectives of the current study were to describe the prevalence and spectrum of autosomal monosomies in an unselected cohort of patients with known or suspected hematologic malignancies. Bone marrow cytogenetic studies (24,262) were performed at our institution between 1989 and 2009. An abnormal karyotype was demonstrated in 6,565 cases (∼27{\%}); of these, 1,365 (∼21{\%}) included autosomal monosomies that occurred as sole (n = 133; ∼10{\%}), part of two (n = 82; ∼6{\%}) or more (n = 1,150; ∼84{\%}) anomalies. All 22 autosomes were involved, but monosomy 7 was by far the most frequent, constituting ∼80{\%} of all isolated monosomies and the highest fraction of those with two or more abnormalities. Other recurrent sole monosomies included chromosomes 20 (∼11{\%}) and 21 (∼4{\%}). Monosomy 13 (∼10{\%}), 20 (∼8{\%}), 18 (∼7{\%}), 17 (∼6{\%}), 21 (∼5{\%}), 5 (∼5{\%}), and 12 (∼4{\%}) were also recurrent in the setting of ≥2 abnormalities. Bone marrow histology and clinical information were reviewed in all cases with isolated monosomy; associated clinical phenotypes were MDS (n = 60; 52 were -7), AML (n = 32; 31 were -7), myeloproliferative neoplasms (n = 16; 10 were -7), chronic myelomonocytic leukemia (CMML; n = 10; 9 were -7) and other nonmyeloid malignancies (n = 15; 4 were -7). Sole monosomy 20 (n = 14; six MDS, five MPN, and three nonmyeloid) was not seen in AML or CMML. Sole monosomy 21 was more frequent in nonmyeloid as opposed to myeloid cases.",
author = "Sania Raza and Fareeda Tahernazerhussain and Patnaik, {Mrinal M} and Ryan Knudson and {Van Dyke}, Daniel and Ayalew Tefferi",
year = "2011",
month = "4",
doi = "10.1002/ajh.21988",
language = "English (US)",
volume = "86",
pages = "353--356",
journal = "American Journal of Hematology",
issn = "0361-8609",
publisher = "Wiley-Liss Inc.",
number = "4",

}

TY - JOUR

T1 - Autosomal monosomies among 24,262 consecutive cytogenetic studies

T2 - Prevalence, chromosomal distribution and clinicopathologic correlates of sole abnormalities

AU - Raza, Sania

AU - Tahernazerhussain, Fareeda

AU - Patnaik, Mrinal M

AU - Knudson, Ryan

AU - Van Dyke, Daniel

AU - Tefferi, Ayalew

PY - 2011/4

Y1 - 2011/4

N2 - Monosomal karyotype (MK) has recently been associated with poor prognosis in acute myeloid leukemia (AML), myelodysplastic syndromes (MDS), and primary myelofibrosis (PMF). The objectives of the current study were to describe the prevalence and spectrum of autosomal monosomies in an unselected cohort of patients with known or suspected hematologic malignancies. Bone marrow cytogenetic studies (24,262) were performed at our institution between 1989 and 2009. An abnormal karyotype was demonstrated in 6,565 cases (∼27%); of these, 1,365 (∼21%) included autosomal monosomies that occurred as sole (n = 133; ∼10%), part of two (n = 82; ∼6%) or more (n = 1,150; ∼84%) anomalies. All 22 autosomes were involved, but monosomy 7 was by far the most frequent, constituting ∼80% of all isolated monosomies and the highest fraction of those with two or more abnormalities. Other recurrent sole monosomies included chromosomes 20 (∼11%) and 21 (∼4%). Monosomy 13 (∼10%), 20 (∼8%), 18 (∼7%), 17 (∼6%), 21 (∼5%), 5 (∼5%), and 12 (∼4%) were also recurrent in the setting of ≥2 abnormalities. Bone marrow histology and clinical information were reviewed in all cases with isolated monosomy; associated clinical phenotypes were MDS (n = 60; 52 were -7), AML (n = 32; 31 were -7), myeloproliferative neoplasms (n = 16; 10 were -7), chronic myelomonocytic leukemia (CMML; n = 10; 9 were -7) and other nonmyeloid malignancies (n = 15; 4 were -7). Sole monosomy 20 (n = 14; six MDS, five MPN, and three nonmyeloid) was not seen in AML or CMML. Sole monosomy 21 was more frequent in nonmyeloid as opposed to myeloid cases.

AB - Monosomal karyotype (MK) has recently been associated with poor prognosis in acute myeloid leukemia (AML), myelodysplastic syndromes (MDS), and primary myelofibrosis (PMF). The objectives of the current study were to describe the prevalence and spectrum of autosomal monosomies in an unselected cohort of patients with known or suspected hematologic malignancies. Bone marrow cytogenetic studies (24,262) were performed at our institution between 1989 and 2009. An abnormal karyotype was demonstrated in 6,565 cases (∼27%); of these, 1,365 (∼21%) included autosomal monosomies that occurred as sole (n = 133; ∼10%), part of two (n = 82; ∼6%) or more (n = 1,150; ∼84%) anomalies. All 22 autosomes were involved, but monosomy 7 was by far the most frequent, constituting ∼80% of all isolated monosomies and the highest fraction of those with two or more abnormalities. Other recurrent sole monosomies included chromosomes 20 (∼11%) and 21 (∼4%). Monosomy 13 (∼10%), 20 (∼8%), 18 (∼7%), 17 (∼6%), 21 (∼5%), 5 (∼5%), and 12 (∼4%) were also recurrent in the setting of ≥2 abnormalities. Bone marrow histology and clinical information were reviewed in all cases with isolated monosomy; associated clinical phenotypes were MDS (n = 60; 52 were -7), AML (n = 32; 31 were -7), myeloproliferative neoplasms (n = 16; 10 were -7), chronic myelomonocytic leukemia (CMML; n = 10; 9 were -7) and other nonmyeloid malignancies (n = 15; 4 were -7). Sole monosomy 20 (n = 14; six MDS, five MPN, and three nonmyeloid) was not seen in AML or CMML. Sole monosomy 21 was more frequent in nonmyeloid as opposed to myeloid cases.

UR - http://www.scopus.com/inward/record.url?scp=79953047317&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79953047317&partnerID=8YFLogxK

U2 - 10.1002/ajh.21988

DO - 10.1002/ajh.21988

M3 - Article

VL - 86

SP - 353

EP - 356

JO - American Journal of Hematology

JF - American Journal of Hematology

SN - 0361-8609

IS - 4

ER -